New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 40474602.
- Also identified by DOI 10.1002/ana.27270 and PMC identifier 12278195.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The advances achieved against multiple sclerosis (MS) represent one of the great success stories of modern molecular medicine. The development of therapies with increasing selectivity and safety, guided by gains in understanding the fundamental immunology, neurobiology, genetics, and triggers of this disease, have broadened the traditional focus on treatment, adding realistic possibilities for prevention and repair. Here, we summarize recent advances that have together transformed the disease from the most common crippler of young adults in the western world to its place today as a condition in which most newly diagnosed patients can anticipate lives free from disability. ANN NEUROL 2025;98:317-328.
Medical subject headings
- Multiple Sclerosis